(Q36617488)

15 August 2017

A high incidence of vertebral fracture in women with breast cancer (English)

1 reference

15 August 2017

1 reference

1 reference

J A Kanis

1

1 reference

15 August 2017

E V McCloskey

2

1 reference

15 August 2017

T Powles

3

1 reference

15 August 2017

A H Paterson

4

1 reference

15 August 2017

S Ashley

5

1 reference

15 August 2017

T Spector

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

7-8

1 reference

15 August 2017

1179-1181

1 reference

Assessment of response and recurrence in breast cancer

15 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362233

Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites

30 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362233

Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study

28 June 2018

1 reference

12 December 2020

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

12 December 2020

Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer

1 reference

12 December 2020

Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial

1 reference

12 December 2020

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

12 December 2020

Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study

1 reference

12 December 2020

Guidelines for diagnosis and management of osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

The assessment of vertebral deformity: a method for use in population studies and clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

Parathyroid hormone-like proteins: biochemical responses and receptor interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

The relationship of gonadal activity and chemotherapy-induced gonadal damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690188

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690188

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

10098755

1 reference